Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Januar 2023 - 11:15PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the global leader in enabling
pharma, biotech, and consumer health partners to optimize
development, launch, and supply of better patient treatments across
multiple modalities, today announced that members of its executive
leadership team will participate at the 41st Annual J.P. Morgan
Healthcare Conference on January 9, 2023 at 5:15 p.m. EST.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent Catalent is the global leader in enabling
pharma, biotech, and consumer health partners to optimize product
development, launch, and full life-cycle supply for patients around
the world. With broad and deep scale and expertise in development
sciences, delivery technologies, and multi-modality manufacturing,
Catalent is a preferred industry partner for personalized
medicines, consumer health brand extensions, and blockbuster drugs.
Catalent helps accelerate over 1,000 partner programs and launch
over 150 new products every year. Its flexible manufacturing
platforms at over 50 global sites supply around 80 billion doses of
nearly 8,000 products annually. Catalent’s expert workforce of
approximately 18,000 includes more than 3,000 scientists and
technicians. Headquartered in Somerset, New Jersey, the company
generated nearly $5 billion in revenue in its 2022 fiscal year. For
more information, visit www.catalent.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230103005777/en/
Investors: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024